Ignite Creation Date:
2025-12-26 @ 10:37 AM
Ignite Modification Date:
2026-03-02 @ 5:55 PM
Study NCT ID:
NCT01854528
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2013-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Hepatitis C Infection | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Partial responder | View |
| None | Interferon free | View |
| None | Treatment-experienced | View |
| None | Relapser | View |
| None | Hepatitis C Virus | View |
| None | Null responder | View |
| None | Hepatitis C Genotype 1 | View |
| None | paritaprevir | View |
| None | ombitasvir | View |
| None | dasabuvir | View |
| None | ribavirin | View |
| None | Viekira PAK | View |
| None | Chronic hepatitis C | View |